Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease

Functional Neurology

Volumn 18, Issue 3, 2003, Pages 149-153

  Wang, Xiao Ping ^a,b   Yang, Ren Min ^b   Ren, Ming Shan ^b   Sun, Bo Min ^b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Serum sulphydryl; Sodium dimercaptosulphonate; Tensiomin; Urinary copper excretion; Wilson's disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTICOPPER AGENT; CAPTOPRIL; COPPER; DIMERCAPTOSULFONATE SODIUM; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LEUKOPENIA; MALE; OPEN STUDY; PORTAL HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYNCOPE; URINE LEVEL; WILSON DISEASE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CAPTOPRIL; CHELATING AGENTS; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; TREATMENT OUTCOME; UNITHIOL;

EID: 0348134528     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chu NS, Hung TP. Geographic variations in Wilson's disease. J Neurol Sci. 1993;117:1-7
2. Frydman M, Bonne-Tamir B, Farrer LA et al. Assignment of the gene for Wilson disease to chromosome 13: Linkage to the esterase D locus. Proc Natl Acad Sci USA 1985;82:1819-1821
3. Wang XP, Wang XH, Bao YC et al. Apolipoprotein E genotypes in Chinese patients with Wilson's disease. QJM 2003;96:541-542
4. Walshe JM, Yealland M. Wilson's disease: The problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 1992;55:692-696
5. Wang XP, Yang RM. Movement disorders possibly induced by traditional Chinese herbs. Eur J Neurol 2003;50:153-159
6. Brewer GJ. Wilson's disease. Curr Treat Options Neurol 2000;2:193-204
7. Dastur DK, Manghani DK, Wadia NH. Wilson's disease in India I. Geographic, genetic and clinical aspects in 16 families. Neurology 1968;18:21-31
8. Ren M, Yang R. Clinical curative effects of dimercaptosuccinic acid on hepatolenticular degeneration and the impact of DMSA on the biliary trace elements. Chin Med J (Engl) 1997;110:694-697
9. Aposhian HV. DMSA and DMPS - Water-soluble antidotes for heavy metal poisoning. Ann Rev Pharmacol Toxicol 1983;23:193-215.
10. Chiang HT, Cheng JS, Lin M, Tseng WS, Chang JM, Lai KH. Haemodynamic effects of enalaprilat on portal hypertension in patients with HbsAg positive cirrhosis. J Gastroenterol Hepatol 1995;10:256-260
11. Wang XP. Wilson disease: Asymptomatic or late-onset type? Acta Neurol Scand 1996;94:421-422
12. Hauftova D, Korbel J, Jancik F, Kuhr I, Ferenc M. Treatment of Wilson's disease using triethylenetetramine dihydrochloride (TETA). Ceskoslovenska Gastroenterologie a Vyziva 1978;32:538-539
13. Dahlman T, Hartvig P, Lofholm M, Nordlinder H, Loof L, Westermark K. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine). QJM 1995;88:609-616
14. Brewer GJ, Johnson V, Dick RD, Kluin KJ, Fink JK, Brunberg JA. Treatment of Wilson disease with ammonium tetrathiomolybdate II: Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 1996;53:1017-1025
15. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: Indication and outcome. Hepatology 1994;19:583-587
16. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992;71:139-164
17. Rodo M, Czonkowska A, Pulawska M, Swiderska M, Tarnacka B, Wehr H. The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients. Eur J Neurol 2000;7:491-494
18. Von Herbay A, De Groot H, Hegi U, Stremmel W, Strohmeyer G, Sies HJ. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol 1994;20:41-46
19. Khaper N, Singal PK. Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J Am Coll Cardiol 2001;37:1461-1466
20. Ramalho FS, Ramalho LN, Castro-e-Silva Junior O, Zucoloto S, Correa FM. Effect of angiotensin-converting enzyme inhibitors on liver regeneration in rats. Hepatogastroenterology 2002;49:1347-1351
21. El-Khatib AS, Mansour MA. Prior treatment with captopril attenuates carbon tetrachloride-induced liver injury in mice. Res Commun Mol Pathol Pharmacol 2001;110:3-16
22. Jonsson JR, Clouston AD, Ando Y, et al. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001;121:148-155
23. Nasr AA, El-Hak NG, Settein ME, Khafagy MA, Tadros MT. Effects of angiotensin-converting enzyme inhibitors and sclerotherapy on portal hemodynamics in patients with portal hypertension. Hepatogastroenterology 2000;47:795-806
24. Ren MS, Hu WB, Zhang Z et al. Copper-chelating therapeutic effect in Wilson disease with different clinical phenotypes and polymorphisms of ATP7B gene. World J Gastroenterol 1998;4:340-342
25. Riordan SM, Williams R. The Wilson's disease gene and phenotypic diversity. J Hepatol 2001;34:165-171